Guest guest Posted December 11, 2007 Report Share Posted December 11, 2007 Hello Everyone: I am a new member and wanted to find out if anyone has used testosterone pellets. They last a lot longer than any other option and I am considering it since it is FDA approved. Any thoughts? .. From http://www.medscape.com/viewarticle/550321_6 Subcutaneous Testosterone Implants (T Pellets/Depot T) Pharmacologic Profile Testosterone has also been formulated as fused cylindrical crystalline implants for TRT (Testopel®, Bartor Pharmaceuticals, Rye, New York). T pellets serve as a nearly ideal depot, maintaining normal serum levels of T for months. Once implanted, T pellets form a slowly dissolving subdermal depot with zero-order release kinetics, such that T absorption is complete or nearly complete by treatment day 189.[62, 63] T pellets have among the longest durations of biologic activity among all forms of TRT, with a mean residence time of 87 days and a half-life of 70.8 days.[63] Approximately 1.18 mg of T is released from each 200 mg pellet daily. Clinical Studies In a study involving 50 hypogonadal men (ages 18–61 years) with serum T<104 ng/dl (mean T = 33.7 ng/dl), a European group implanted six 200 mg T pellets in each patient.[63] After implantation, serum T peaked at ~1326 ng/dl within 30 min.[63] The mean serum T exceeded 288 ng/dl up to treatment days 147–246. Treatment effects of T pellets waned after about 6 months, with patients reporting declining libido and erectile function.[63] Similar pharmacokinetic profiles were reported in an Australian study of hypogonadal men receiving T pellets 600–1200 mg,[64] which showed that absorption rate was not influenced by the sizes or number of pellets implanted. In a review of 13 years of experience with T pellets, Handelsman reported favorable clinical outcomes, with few AEs and a treatment continuation rate of approximately 93%[62] ( Table 6 ). Other study findings are shown in Table 6.[63, 64, 65] In a number of studies, patients were so satisfied with T pellet treatment that they elected to continue receiving this form of therapy rather than return to their prior form of TRT. The chief AEs with T pellets include pellet extrusion; minor bleeding, which is typically insignificant and controlled by applying pressure to the surgical wound; and infection, which is infrequent and may also result in pellet extrusion. Some patients develop fibrosis (scarring, nodules) around implantation sites, but this typically does not prevent further implantations. Prospective randomized clinical trials have demonstrated that neither washing T pellets in filtered sterile alcohol nor soaking them with an antibiotic (gentamicin) prior to implantation significantly reduces the likelihood of pellet extrusion.[65, 66] However, the use of povidone-iodine skin disinfectant prior to the procedure does appear to lower pellet extrusion rates. The likelihood of pellet extrusion may decline with increasing operator experience. User and Prescriber Considerations In an office procedure lasting approximately 15 min, T pellets are implanted into the subdermal fat of the lower abdominal wall using a stainless-steel wide-bore trocar under sterile conditions and a local anesthetic. Through a small (0.5–1.0 cm) incision ≥5 cm from the midline at the umbilical level, a 7.5 F gauge 7-cm long trocar with an inner diameter of 5 mm is introduced and the implants discharged into fan-like tracks 5–10 cm from the puncture site using an obturator. In addition to the lower abdomen, implantation sites include the deltoid, proximal thigh, or buttocks. Most patients return to work the day of, or the day after, implantation but are advised to avoid bending or vigorous physical activity Regards, Vergel powerusa dot org Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.